ESC 365 - Optimal serum uric acid levels for hypertension:5-year cohort study

ESC Premium Access

Optimal serum uric acid levels for hypertension:5-year cohort study

Session: Poster Session 2 - Hypertension risk factors and life style

Topic: Epidemiology, Prognosis, Outcome

Speaker: Associate Professor M. Kuwabara (Shimotsuke, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Associate Professor Masanari Kuwabara

Jichi Medical University, Shimotsuke (Japan)

1 presentation

1 follower

14 more presentations in this session

Blood pressure and LDL-cholesterol control in patients with primary hypertension is far from optimal: results from a large observational, multicentric, prospective study

Speaker: Professor D. Vinereanu (Bucharest, RO)

High density lipoprotein cholesterol (HDL-C) levels and endothelial glycocalyx integrity in treated hypertensive patients

Speaker: Doctor H. Triantafyllidi (Athens, GR)

Clinical profile of patients initiating evolocumab in Spanish Cardiology Units: A RETrospective, Observational Study of Real-World Clinical Practice (RETOSS-Cardio)

Speaker: Professor V. Barrios (Madrid, ES)

Triglycerides are related to left ventricular mass in hypertensive patients, independently of other cardiometabolic risk factors: The effect of gender

Elevated serum uric acid associated with hypertension in healthy individuals

Speaker: Doctor C. Liu (Taipei, TW)

Access the full session

Poster Session 2 - Hypertension risk factors and life style

Speakers: Associate Professor M. Kuwabara, Professor D. Vinereanu, Doctor H. Triantafyllidi, Professor V. Barrios, Doctor C. Liu

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources